Cord blood stem cell therapy (Translational Biosciences)

N/A

Report date: 2024/10/18 20:00:35

Base Information

Drug NameCord blood stem cell therapy (Translational Biosciences)

Drug Alias NamehuMSChuman UC-MSCUC-MSC (Translational Biosciences)Human umbilical cord tissue-derived mesenchymal stem cells

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, KneeArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPanama

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTranslational Biosciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTranslational Biosciences

Active IndicationsN/A

Inactive IndicationsOsteoarthritis, KneeArthritis, Rheumatoid

Other Information

ATC CodeN/A